TIMP3 rs121918350: Pathogenic Variant for Vision Loss
The rs121918350 variant is an extremely rare genetic change in the TIMP3 gene associated with Sorsby fundus dystrophy, a condition causing progressive vision loss. This pathogenic missense substitution can lead to choroidal neovascularization and macular degeneration.
What each genotype means
Typical vision-related risk profile
This is the most common genotype and represents the absence of the specific pathogenic mutation associated with Sorsby fundus dystrophy. It is considered the reference or normal configuration for this position in the TIMP3 gene.
This genotype is present in the vast majority of the human population across all ancestries.
Increased risk of retinal dystrophy
This genotype indicates the presence of one copy of the rare, pathogenic variant associated with Sorsby fundus dystrophy, an autosomal dominant condition. Because the condition is dominant and fully penetrant, individuals with this genotype are at high risk for developing progressive central vision loss, often beginning in the third to fourth decade of life. You should discuss this finding with a specialized ophthalmologist or a certified genetic counselor for appropriate clinical monitoring.
Extremely rare; the minor allele frequency is less than 0.00005 in the gnomAD database.
Significant risk of retinal dystrophy
While this genotype is exceptionally rare in the general population, carrying two copies of the pathogenic variant is consistent with the presence of the mutation linked to Sorsby fundus dystrophy. Given the autosomal dominant nature of this condition, this genotype carries a high likelihood of manifesting retinal degenerative symptoms. It is strongly recommended that you consult with a medical geneticist or an ophthalmologist specializing in retinal diseases to discuss your health profile.
Not commonly observed in general population datasets; considered extremely rare.
Understanding the rs121918350 Variant
The rs121918350 variant, also known clinically as p.Ser181Cys, represents a specific alteration in the DNA sequence of the TIMP3 gene. This change involves the substitution of the amino acid serine with cysteine at position 181 of the TIMP3 protein, a critical site for its function. As a missense mutation, this alteration can impact the protein's structure, stability, or interaction with other molecules. Genetic variants like rs121918350 are meticulously cataloged, allowing researchers to track their presence and effects. While the vast majority of human DNA is identical, such single-letter changes in the genetic code can have significant biological consequences. This particular variant is classified as pathogenic, indicating it is recognized in scientific literature as a cause of disease.
The Role of the TIMP3 Gene in Vision
The TIMP3 gene encodes the Tissue Inhibitor of Metalloproteinases 3 protein, a crucial component of the extracellular matrix, particularly important for maintaining the structural integrity of the eye. TIMP3 acts by regulating the activity of matrix metalloproteinases (MMPs), enzymes that break down components of the extracellular matrix. In the eye, TIMP3 helps preserve the Bruch's membrane, a vital layer separating the retina from the underlying choroid. When the TIMP3 protein is altered by a variant like rs121918350, its regulatory function is impaired. This disruption can lead to the accumulation of abnormal deposits and the degradation of structural barriers, potentially triggering the growth of abnormal blood vessels in the choroid (choroidal neovascularization), a process that severely impacts vision and can lead to macular degeneration.
Research and Clinical Evidence for rs121918350
The link between the rs121918350 variant and Sorsby fundus dystrophy is well-established in clinical and genetic research. Sorsby fundus dystrophy is a rare, autosomal dominant inherited eye disorder characterized by early-onset central vision loss, typically beginning in adulthood. Numerous case studies and family-based genetic analyses have confirmed this variant's role in causing the condition. Due to its autosomal dominant inheritance pattern, inheriting just one copy of the rs121918350 variant is generally sufficient to manifest the disease. While the molecular mechanisms linking this specific mutation to retinal degeneration are understood, ongoing research aims to further elucidate the precise pathways involved. It is important to note that while the evidence for this variant's pathogenicity is strong, individual clinical outcomes can vary, and other factors may influence disease progression.
Population Frequency and Distribution
The rs121918350 variant is exceptionally rare in the general population. Data from the Genome Aggregation Database (gnomAD) indicates an allele frequency below 0.00005, meaning it is found in a very small fraction of individuals studied across diverse ancestries. Its extreme rarity means it is not typically included in common genetic testing panels. The variant is almost exclusively identified in individuals and families diagnosed with Sorsby fundus dystrophy. There is no current evidence to suggest that rs121918350 is prevalent in any specific ethnic or geographic group; its identification is primarily driven by clinical diagnostic testing for inherited retinal disorders.
Navigating Genetic Information and Vision Health
Information about the rs121918350 variant represents a clinical genetic finding, not a general health indicator. This content is for educational purposes and should not be used for self-diagnosis or medical decision-making. If you have concerns about your vision or a family history of retinal diseases, consulting a medical geneticist or a specialized ophthalmologist is the recommended course of action. These healthcare professionals can provide personalized interpretation of genetic results within the context of your health history and discuss appropriate clinical evaluations. Genetic testing for rare, pathogenic variants should always be conducted under the supervision of a qualified healthcare provider.
How common is this variant?
The rs121918350 variant is extremely rare, with an allele frequency below 0.00005 in the gnomAD database across various ancestries. It is primarily identified in individuals with Sorsby fundus dystrophy.
Frequently asked questions
What is Sorsby fundus dystrophy?
Sorsby fundus dystrophy is a rare, inherited eye condition that causes progressive loss of central vision. It is caused by mutations in the TIMP3 gene, leading to degeneration in the back of the eye.
How is the rs121918350 variant inherited?
This variant follows an autosomal dominant inheritance pattern. This means that inheriting just one copy of the variant from a parent is typically sufficient to cause Sorsby fundus dystrophy.
Can this variant be tested for at home?
Most standard direct-to-consumer genetic tests do not screen for this specific, extremely rare variant. Clinical genetic testing for TIMP3 mutations is usually performed in a medical setting if a hereditary retinal disorder is suspected.
What are the symptoms of Sorsby fundus dystrophy?
Symptoms typically include progressive loss of central vision, often starting in adulthood. This can lead to difficulties with reading, recognizing faces, and driving. The condition can also cause night blindness and color vision defects.
Is there a treatment for Sorsby fundus dystrophy?
Currently, there is no cure for Sorsby fundus dystrophy. However, treatments such as anti-VEGF injections may be used to manage complications like choroidal neovascularization. Discuss management options with a retinal specialist.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918350?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TIMP3
Encodes the Ser181Cys mutation in TIMP3, a classic pathogenic driver of Sorsby fundus dystrophy leading to premature macular choroidal neovascularization.
Pathogenic missense variant (p.Ser181Cys) in TIMP3 causing classic Sorsby fundus dystrophy characterized by choroidal neovascularization and macular degeneration.
Variant in the TIMP3 signal sequence region associated with abnormal cleavage and atypical macular dystrophy.